Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92,935,152
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
3,883,345
-
Shares change
-
-352,125
-
Total reported value, excl. options
-
$2,545,096
-
Value change
-
-$383,818
-
Number of buys
-
12
-
Number of sells
-
-12
-
Price
-
$0.6517
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q4 2022
29 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,883,345 shares
of 92,935,152 outstanding shares and own 4.2% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (1,143,745 shares), Affinity Asset Advisors, LLC (883,654 shares), VANGUARD GROUP INC (640,863 shares), Worth Venture Partners, LLC (281,889 shares), swisspartners Ltd. (180,000 shares), HighTower Advisors, LLC (125,852 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (105,809 shares), RENAISSANCE TECHNOLOGIES LLC (105,300 shares), Mill Creek Capital Advisors, LLC (104,631 shares), and GEODE CAPITAL MANAGEMENT, LLC (61,202 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.